Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency Syndrome

In many clinical and epidemiologic studies, periodically measured disease markers are used to monitor progression to the onset of disease. Motivated by a study of CD4 counts in men infected with human immunodeficiency virus (HIV) at risk for acquired immunodeficiency syndrome (AIDS), we developed a joint model for analysis of both longitudinal and event time data. We use a longitudinal model for continuous data that incorporates a mean structure dependent on covariates, a random intercept, a stochastic process, and measurement error. A central component of the longitudinal model is an integrated Ornstein–Uhlenbeck stochastic process, which represents a family of covariance structures with a random effects model and Brownian motion as special cases. The regression model for the event time data is a proportional hazards model that includes the longitudinal marker as a time-dependent variable and other covariates. A Markov chain Monte Carlo algorithm was developed for fitting the joint model. The joint modeling approach is evaluated and compared with the approach of separate modeling through simulation studies, and it is applied to CD4 counts and AIDS event time data from a cohort study of HIV-infected men. The joint estimation approach allows the simultaneous estimation of the effect of baseline covariates on the progression of CD4 counts and the effect of the current CD4 count and baseline covariates on the hazard of AIDS. The joint modeling approach also gives a way to incorporate measurement error in CD4 counts into a hazard model.

[1]  C. Sabin,et al.  The incubation period of AIDS. , 1997, AIDS.

[2]  James J. Goedert,et al.  Effect of age at seroconversion on the natural AIDS incubation distribution , 1994, AIDS.

[3]  J. Taylor,et al.  CD4+ T-cell number at the time of acquired immunodeficiency syndrome. , 1995, American journal of epidemiology.

[4]  N. Jewell,et al.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. , 1989, Journal of acquired immune deficiency syndromes.

[5]  M. Wulfsohn,et al.  A joint model for survival and longitudinal data measured with error. , 1997, Biometrics.

[6]  W. K. Hastings,et al.  Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .

[7]  J. M. Taylor,et al.  A comparison of smoothing techniques for CD4 data measured with error in a time-dependent Cox proportional hazards model. , 1998, Statistics in medicine.

[8]  M. Feinleib,et al.  Statistical Models for Longitudinal Studies of Health , 1992 .

[9]  J. Margolick,et al.  Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.

[10]  Victor DeGruttola,et al.  Modeling The Relationship Between Progression Of CD4-Lymphocyte Count And Survival Time , 1992 .

[11]  A. Tsiatis,et al.  Nonparametric survival estimation using prognostic longitudinal covariates. , 1996, Biometrics.

[12]  Andrew Gelman,et al.  General methods for monitoring convergence of iterative simulations , 1998 .

[13]  J M Taylor,et al.  Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. Multicentre AIDS Cohort Study. , 1990, Statistics in medicine.

[14]  N M Laird,et al.  Mixture models for the joint distribution of repeated measures and event times. , 1997, Statistics in medicine.

[15]  R. Detels,et al.  Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals. , 1991, AIDS.

[16]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[17]  A. Shapiro Monte Carlo Sampling Methods , 2003 .

[18]  Yudi Pawitan,et al.  Modeling a Marker of Disease Progression and Onset of Disease , 1992 .

[19]  David J. Spiegelhalter,et al.  Introducing Markov chain Monte Carlo , 1995 .

[20]  K. Bailey,et al.  Analysing changes in the presence of informative right censoring caused by death and withdrawal. , 1988, Statistics in medicine.

[21]  D. Thomas,et al.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. , 1996, Statistics in medicine.

[22]  R. Prentice,et al.  Further results on covariate measurement errors in cohort studies with time to response data. , 1989, Statistics in medicine.

[23]  Sylvia Richardson,et al.  Markov Chain Monte Carlo in Practice , 1997 .

[24]  Jeremy M. G. Taylor,et al.  A Stochastic Model for Analysis of Longitudinal AIDS Data , 1994 .

[25]  J. Phair,et al.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.

[26]  J M Taylor,et al.  Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts? , 1998, Statistics in medicine.

[27]  BerzuiniCarlo,et al.  A Unified Approach for Modeling Longitudinal and Failure Time Data, With Application in Medical Monitoring , 1996 .

[28]  M. Wulfsohn,et al.  Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS , 1995 .

[29]  Walter R. Gilks,et al.  Strategies for improving MCMC , 1995 .

[30]  R. Prentice Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.

[31]  Donald Geman,et al.  Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images , 1984, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[32]  R. Prentice Covariate measurement errors and parameter estimation in a failure time regression model , 1982 .